Two Cases of Primary Esophageal Diffuse Large B Cell Lymphoma: Therapeutic Considerations and a Literature Review.
10.3904/kjm.2015.88.2.224
- Author:
Ji Hye KIM
1
;
Yun Hwa JUNG
;
In Sook WOO
;
Chi Wha HAN
;
Min Woo SEO
;
Sang Hoon YOO
;
So Young HA
Author Information
1. Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. cwhan@unitel.co.kr
- Publication Type:Case Report
- Keywords:
Esophagus;
Diffuse large-cell lymphoma
- MeSH:
Drug Therapy;
Esophagus;
Lymphoma;
Lymphoma, B-Cell*;
Lymphoma, B-Cell, Marginal Zone;
Lymphoma, Large B-Cell, Diffuse
- From:Korean Journal of Medicine
2015;88(2):224-230
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Primary esophageal lymphoma is very rare, and most reported cases are histologically mucosa-associated lymphoid tissue lymphoma. Therefore, the principle treatment strategy for primary esophageal lymphoma focuses on local treatments, such as endoscopic mucosal resection or radiation therapy, but systemic chemotherapy plays the central role in the treatment of diffuse large B cell lymphoma (DLBCL). Generally, standard treatment for DLBCL is six or three cycles of R-CHOP chemotherapy followed by involved field radiation therapy according to stage. However, the optimal treatment strategy for primary esophageal DLBCL, and the role of additional radiation is not settled, due to a paucity of cases. Moreover, the clinical characteristics related to the etiology and natural course are also unknown. Here, we present two cases of primary esophageal DLBCL with a literature review.
